Organization
ChemoCentryx
16 clinical trials
Clinical trial
A Randomized , Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis SuppurativaStatus: Completed, Estimated PCD: 2021-01-14
Clinical trial
A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/AzathioprineStatus: Completed, Estimated PCD: 2019-09-07
Clinical trial
An Open Label, Intra-Subject Dose Escalation Study of CCX140-B in Subjects With Primary Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic SyndromeStatus: Terminated, Estimated PCD: 2020-06-24
Clinical trial
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis on Background of Cyclophosphamide or Rituximab TreatmentStatus: Completed, Estimated PCD: 2015-10-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Dose Assessment Phase 2 Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitisStatus: Completed, Estimated PCD: 2016-04-24
Clinical trial
A Multinational, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's DiseaseStatus: Completed, Estimated PCD: 2008-08-01
Clinical trial
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2010-10-01
Clinical trial
A Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Effect of CCX140-B on Albuminuria in Subjects With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2013-02-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Testing CCX282-B in the Treatment of Celiac DiseaseStatus: Completed, Estimated PCD: 2008-06-01
Clinical trial
Pilot, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety Clinical Activity of CCX282-B in Patients With Moderate to Severe Crohn's DiseaseStatus: Completed
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid ArthritisStatus: Completed, Estimated PCD: 2010-07-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate TherapyStatus: Completed, Estimated PCD: 2011-07-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX140-B in Diabetic NephropathyStatus: Completed, Estimated PCD: 2014-08-01
Clinical trial
An Open-Label Phase 2 Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With Immunoglobulin A Nephropathy on Stable RAAS BlockadeStatus: Completed, Estimated PCD: 2015-09-13
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Focal Segmental Glomerulosclerosis (FSGS)Status: Completed, Estimated PCD: 2020-02-19
Clinical trial
A Randomized, Double Blind, Placebo Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan (CCX168) in Patients With C3 GlomerulopathyStatus: Completed, Estimated PCD: 2021-03-03